Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 13:10:1115328.
doi: 10.3389/fcvm.2023.1115328. eCollection 2023.

Long-Term Follow-Up In Paroxysmal Atrial Fibrillation Patients With Documented Isolated Trigger

Zefferino Palamà  1   2 , Antonio Gianluca Robles  1   3 , Matteo Paoletti  1 , Martina Nesti  4 , Ermenegildo De Ruvo  5 , Antonio Scarà  6 , Alessio Borrelli  6 , Gabriele De Masi De Luca  1   7 , Mariano Rillo  2 , Leonardo Calò  5 , Elena Cavarretta  8   9 , Silvio Romano  1 , Luigi Sciarra  1
Affiliations

Long-Term Follow-Up In Paroxysmal Atrial Fibrillation Patients With Documented Isolated Trigger

Zefferino Palamà et al. Front Cardiovasc Med. .

Abstract

Aims: Supraventricular tachycardias may trigger atrial fibrillation (AF). The aim of the study was to evaluate the prevalence of supraventricular tachycardia (SVT) inducibility in patients referred for AF ablation and to evaluate the effects of SVT ablation on AF recurrences.

Methods and results: 249 patients (mean age: 54 ± 14 years) referred for paroxysmal AF ablation were studied. In all patients, only AF relapses had been documented in the clinical history. 47 patients (19%; mean age: 42 ± 11 years) had inducible SVT during the electrophysiological study and underwent an ablation targeted only at SVT suppression. Ablation was successful in all 47 patients. The ablative procedures were: 11 slow-pathway ablations for atrioventricular nodal re-entrant tachycardia; 6 concealed accessory pathway ablations for atrioventricular re-entrant tachycardia; 17 focal ectopic atrial tachycardia ablations; 13 with only one arrhythmogenic pulmonary vein. No recurrences of SVT were observed during the follow-up (32 ± 18 months). 4 patients (8.5%) showed recurrence of at least one episode of AF. Patients with inducible SVT had less structural heart disease and were younger than those without inducible SVT.

Conclusion: A significant proportion of candidates for AF ablation are inducible for an SVT. SVT ablation showed a preventive effect on AF recurrences. Those patients should be selected for simpler ablation procedures tailored only to the triggering arrhythmia suppression.

Keywords: PVI catheter ablation; PVI only; atrial fibrillation ablation; supraventricular tachycardia; tailored approach.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Graphic representation of the results obtained from the electrophysiological study in AF patients with documented trigger. In AVRNT group short RP interval during tachycardia in V1 lead as shown in ECG trace. In AVRT group (due to concealed Kent's bundle) long RP interval during tachycardia in II lead as shown in ECG trace. In FAT group “P on T” phenomena as shown in ECG trace. AVRNT, Atrioventricular nodal re-entrant tachycardia; AVRT, Atrioventricular re-entrant tachycardias; FAT, focal atrial tachycardia.
Figure 2
Figure 2
AF-free survival group in trigger ablation (blue line) and PVI-only (red line) patients of our study and in the control group (grey line) treated with a PVI-only approach without trigger research.
See this image and copyright information in PMC

References

    1. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. (2021) 42:373–498. 10.1093/eurheartj/ehaa612 - DOI - PubMed
    1. Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al. Initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. (1998) 339:659–66. 10.1056/NEJM199809033391003 - DOI - PubMed
    1. Sánchez-Quintana D, López-Mínguez JR, Pizarro G, Murillo M, Cabrera JA. Triggers and anatomical substrates in the genesis and perpetuation of atrial fibrillation. Curr Cardiol Rev. (2012) 8:310–26. 10.2174/157340312803760721 - DOI - PMC - PubMed
    1. Wathen M, Natale A, Wolfe K, Yee R, Klein G. Initiation of atrial fibrillation in the wolff-parkinson-white syndrome: the importance of the accessory pathway. Am Heart J. (1993) 125(3):753–9. 10.1016/0002-8703(93)90167-8 - DOI - PubMed
    1. Brugada J, Mont L, Matas M. Atrial fibrillation induced by atrioventricular nodal reentrant tachycardia. Am J Cardiol. (1997) 79:681–2. 10.1016/S0002-9149(96)00842-9 - DOI - PubMed

LinkOut - more resources